Literature DB >> 9890674

A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets.

S Jacobsen1, J Petersen, S Ullman, P Junker, A Voss, J M Rasmussen, U Tarp, L H Poulsen, G van Overeem Hansen, B Skaarup, T M Hansen, J Pødenphant, P Halberg.   

Abstract

A Danish multicentre study was undertaken of the manifestations, infections, thrombotic events, survival and predictive factors of survival in 513 Danish patients with systemic lupus erythematosus (SLE) according to the 1982 classification criteria of the American College of Rheumatology. The mean duration of follow-up was 8.2 years from diagnosis and 12.8 years from first symptom. This paper describes the most common clinical and laboratory manifestations and their relationship to sex and age at the time of onset and diagnosis. Cluster analysis revealed three clinically defined clusters at the time of disease onset. Cluster 1 (57% of patients) consisted of relatively elderly patients without nephropathy or malar rash, but with a high prevalence of discoid lesions. Cluster 2 (18%) consisted of patients with nephropathy, a third of whom also developed serositis and lymphopenia. The patients of the third cluster (25%) all had malar rash and half were photosensitive. Follow-up showed that the patients of cluster 2 developed azotaemia, large proteinuria, arterial hypertension and myositis significantly more often than did the rest of the patients, but the mortality was not increased. The risk of developing renal end-stage disease was highest in men with early-onset disease.

Entities:  

Mesh:

Year:  1998        PMID: 9890674     DOI: 10.1007/bf01451282

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

Review 1.  Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE.

Authors:  C Vitali; W Bencivelli; D A Isenberg; J S Smolen; M L Snaith; M Sciuto; A d'Ascanio; S Bombardieri
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473

2.  Predominance of renal involvement in male patients with systemic lupus erythematosus.

Authors:  A Blum; A Rubinow; E Galun
Journal:  Clin Exp Rheumatol       Date:  1991 Mar-Apr       Impact factor: 4.473

3.  [Cluster analysis of 109 patients with systemic lupus erythematosus].

Authors:  B Bokemeyer; K G Thiele
Journal:  Klin Wochenschr       Date:  1985-01-15

4.  Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations.

Authors:  M M Ward; S Studenski
Journal:  J Rheumatol       Date:  1990-02       Impact factor: 4.666

5.  Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population.

Authors:  H Jonsson; O Nived; G Sturfelt
Journal:  Medicine (Baltimore)       Date:  1989-05       Impact factor: 1.889

6.  A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus.

Authors:  M M Ward; R P Polisson
Journal:  Arthritis Rheum       Date:  1989-10

7.  Age associated clinical manifestations of systemic lupus erythematosus: a multivariate regression analysis.

Authors:  M M Ward; S Studenski
Journal:  J Rheumatol       Date:  1990-04       Impact factor: 4.666

8.  Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death.

Authors:  J D Reveille; A Bartolucci; G S Alarcón
Journal:  Arthritis Rheum       Date:  1990-01

9.  Variants of SLE--a statistical approach for discrimination of a group of SLE cases into different subgroups sharing symptomatology. A pilot study.

Authors:  M Sedzimirska; A Jacak; C Laba; A Klimczak; A Lange
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1991       Impact factor: 4.291

10.  Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively.

Authors:  A J Swaak; J C Nossent; W Bronsveld; A Van Rooyen; E J Nieuwenhuys; L Theuns; R J Smeenk
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

View more
  27 in total

Review 1.  Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.

Authors:  Laurent Arnaud; Alexis Mathian; Jacques Boddaert; Zahir Amoura
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

2.  Cluster analysis of symptoms among patients with upper extremity musculoskeletal disorders.

Authors:  Judith E Gold; George Piligian; Joseph J Glutting; Alexandra Hanlon; Monique H W Frings-Dresen; Judith K Sluiter
Journal:  J Occup Rehabil       Date:  2010-12

3.  Autoimmune hemolytic anemia in systemic lupus erythematosus: association with thrombocytopenia.

Authors:  Diogo Souza Domiciano; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2010-05-15       Impact factor: 2.980

4.  A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value.

Authors:  S Jacobsen; J Petersen; S Ullman; P Junker; A Voss; J M Rasmussen; U Tarp; L H Poulsen; G van Overeem Hansen; B Skaarup; T M Hansen; J Pødenphant; P Halberg
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

5.  Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus.

Authors:  Joseph F Merola; Stephen D Prystowsky; Christina Iversen; Jose A Gomez-Puerta; Tabatha Norton; Peter Tsao; Elena Massarotti; Peter Schur; Bonnie Bermas; Karen H Costenbader
Journal:  J Am Acad Dermatol       Date:  2013-03-28       Impact factor: 11.527

6.  Genetic linkage of systemic lupus erythematosus to 13q32 in African American families with affected male members.

Authors:  Chao Xing; Courtney Gray-McGuire; Jennifer A Kelly; Phillip Garriott; Hulya Bukulmez; John B Harley; Jane M Olson
Journal:  Hum Genet       Date:  2005-09-28       Impact factor: 4.132

7.  Genetic polymorphisms of dsRNA ligating pattern recognition receptors TLR3, MDA5, and RIG-I. Association with systemic lupus erythematosus and clinical phenotypes.

Authors:  C Enevold; L Kjær; C H Nielsen; A Voss; R S Jacobsen; M L F Hermansen; L Redder; A B Oturai; P E Jensen; K Bendtzen; S Jacobsen
Journal:  Rheumatol Int       Date:  2014-04-10       Impact factor: 2.631

8.  Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis.

Authors:  Jennifer L Medlin; Karen E Hansen; Sara S McCoy; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2018-01-31       Impact factor: 5.532

Review 9.  A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus.

Authors:  Jennifer L Medlin; Karen E Hansen; Sara R Fitz; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2016-01-21       Impact factor: 5.532

10.  [Lupusnephritis].

Authors:  M Haubitz
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.